Analyst Ratings for Arrowhead Pharma (ARWR)
ARWR Rating Summary
ARWR Price Target Summary
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$96.92 (+64.5%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
Avg. $ Target:
$96.92 (+64.5%)
* Over Last 12-Mos
Rating Score: 7.8 / 10
Percentile Rank: 81%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Neutral (N/A) |
74.00 (N/A) |
71.86 (58.92) |
-18.01% | Details |
| 9/8/2026 | Citi | Eric Joseph | New Coverage | Buy (N/A) |
108.00 (N/A) |
86.49 (58.92) |
-31.88% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
